Gilead's gets orphan status in Australia for Viread
This article was originally published in Scrip
Executive Summary
The Australian Therapeutics Goods Administration (TGA) has granted orphan status to Gilead's antiretroviral treatment Viread (tenofovir disoproxil fumarate) for paediatric use.